Benzinga | Sep 25, 2020 08:02AM EDT

FDA Approves Bausch + LombAlaway Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035%; NOTE: An Affiliate Of Bausch Health Acquired The US Rights To Alaway Preservative Free From Eton In 2019

LAVAL,QC and DEER PARK, Ill., Sept. 25, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (TSX:BHC) ("Bausch Health"), Bausch + Lomb, a leading global eye health business, and Eton Pharmaceuticals, Inc. (NASDAQ:ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Alaway(r) Preservative Free (ketotifen fumarate) ophthalmic solution, 0.035%, antihistamine eye drops (EM-100), as the first over-the-counter (OTC) preservative-free formulation eye drop approved to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair and dander, which is one of the eye symptoms that affects approximately 80 percent of people with allergies.[1]Preservatives commonly used in eye drops can cause allergic reactions in some people that can lead to redness, irritation, itching or tearing.[2],[3]